In vitro analysis of antiangiogenic activity of fungi isolated from clinical cases of equine keratomycosis

Veterinary Ophthalmology

Volumn 3, Issue 2-3, 2000, Pages 145-151

  Welch, Patrick M ^a   Gabal, Moustafa ^a   Betts, Daniel M ^a   Whelan, Nick C ^a   Studer, Michele E ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Angiogenesis assay; Antiangiogenic; Corneal neovascularization; Equine; Keratomycosis

Indexed keywords

ASPERGILLUS SP.; EQUIDAE; FUNGI; FUSARIUM SP.;

EID: 0442277783     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-5224.2000.00132.x     Document Type: Article

References (23)

1. Barton MH. Equine keratomycosis. Compendium of Continuing Education for the Practicing Veterinarian 1992; 14: 936-944.
2. Thomas PA. Mycotic keratitis - an underestimated mycosis. Journal of Medical and Veterinary Mycology 1994; 32: 235-256.
3. Brooks DE. Equine ophthalmology. In: (ed. Gelatt KN) Veterinary Ophthalmology. Lippencott Williams & Wilkins, Philadelphia, 1999; 1088-1090.
4. Moore CP, Fales WH, Whittington P, Bauer L. Bacterial and fungal isolates from Equidae with ulcerative keratitis. Journal of the American Veterinary Medical Association 1983; 182(6): 600-603.
5. Chmielewski NT, Brooks DE, Smith PJ, Hendrix DV, Whittaker C, Gelatt KN. Visual outcome and ocular survival following iris prolapse in the horse: a review of 32 cases. Equine Veterinary Journal 1997; 29(1): 31-39.
6. Andrew SE, Brooks DE, Smith PJ, Gelatt KN, Chmielewski NT, Whittaker CJ. Equine ulcerative keratomycosis: visual outcome and ocular survivalin 39 cases (1987-1996). Equine Veterinary Journal 1998; 30(2): 109-116.
7. McLaughlin SA, Brightman AH, Helper LC, Manning JP, Tomes JE. Pathogenic bacteria and fungi associated with extraocular disease in the horse. Journal of the American Veterinary Medical Association 1983; 182(3): 241-242.
8. Grahn B, Wolfer J, Keller C et al. Equine keratomycosis: Clinical and laboratory findings in 23 cases. Progress in Veterinary and Comparative Ophthalmology, 1993; 3: 2-7.
9. Gaarder JE, Rebhun WC, Ball MA, Patten V, Shin S, Erb H. Clinical appearances, healing patterns, risk factors, and outcomes of horses with fungal keratitis: 53 cases (1978-1996) [see comments]. Journal of the American Veterinary Medical Association 1998; 213(1): 105-112.
10. Hendrix DV, Brooks DE, Smith PJ, Gelatt KN, Miller TR, Whittaker C et al. Corneal stromal abscesses in the horse: a review of 24 cases. Equine Veterinary Journal 1995; 27(6): 440-447.
11. Raza SK, Mallet AI, Howell SA, Thomas PA. An in-vitro study of the sterol content and toxin production of Fusarium isolates from mycotic keratitis. Journal of Medical Microbiology 1994; 41(3): 204-208.
12. Zhu WS, Wojdyla K, Donlon K, Thomas PA, Eberle HI. Extracellular proteases of Aspergillus flavus. Fungal keratitis, proteases, and pathogenesis. Diagnostic Microbiology and Infectious Disease 1990; 13(6): 491-497.
13. Forster RK. Infectious diseases: fungal diseases. In: (eds Smolin G, Tholt RA) The Cornea. Little, Brown, Boston, 1987: 228-240.
14. Jones BR. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. American Journal of Ophthalmology 1975; 79(5): 719-751.
15. Weiss A. Immunologic diseases of the eye. In: (ed. Parker CP) Clinical Immunology. W.B. Saunders, Philadelphia, 1980: 1145-1175.
16. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. Journal of Cell Biology 1988; 107(4): 1589-1598.
17. Maciag T, Kadish J, Wilkins L, Stemerman MB, Weinstein R. Organizational behavior of human umbilical vein endothelial cells. Journal of Cell Biology 1982; 94(3): 511-520.
18. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980; 288(5791): 551-556.
19. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clinical Cancer Research 1996; 2(11): 1843-1849.
20. Klagsbrun M, Knighton D, Folkman J. Tumor angiogenesis activity in cells grown in tissue culture. Cancer Research 1976; 36(1): 110-114.
21. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. Journal of Experimental Medicine 1971; 133(2): 275-288.
22. Gimbrone MA Jr, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularizarion: an experimental model using the rabbit cornea. Journal of the National Cancer Institute 1974; 52(2): 413-427.
23. Haralabopoulos GC, Grant DS, Kleinman HK, Lelkes PI, Papaioannou SP, Maragoudakis ME. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Laboratory Investigation 1994; 71(4): 575-582.